About Synexus Clinical Research GmbH
Clinical Trials at Synexus Clinical Research GmbH
During the past decade, Synexus Clinical Research GmbH conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Synexus Clinical Research GmbH" #1 sponsor was "Idorsia Pharmaceuticals Ltd." with 2 trials, followed by "Pfizer" with 2 trials
sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored and "Regeneron Pharmaceuticals"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Synexus Clinical Research GmbH"
#1 collaborator was "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Synexus Clinical Research GmbH
According to Clinical.Site data, the most researched conditions in "Synexus Clinical Research GmbH" are
"Insomnia Disorder" (2 trials), "Acute Pain" (1 trials), "Cardiovascular Disease" (1 trials), "Neuropathic Pain" (1 trials) and "Osteoarthritis, Hip" (1 trials). Many other conditions were trialed in "Synexus Clinical Research GmbH" in a lesser frequency.
Clinical Trials Intervention Types at Synexus Clinical Research GmbH
Most popular intervention types in "Synexus Clinical Research GmbH" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Capsaicin" (1 trials), "Daridorexant" (1 trials), "Daridorexant 10 mg" (1 trials) and "Daridorexant 25 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Synexus Clinical Research GmbH
The vast majority of trials in "Synexus Clinical Research GmbH" are
7 trials for "All" genders.
Clinical Trials Status at Synexus Clinical Research GmbH
Currently, there are NaN active trials in "Synexus Clinical Research GmbH".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Synexus Clinical Research GmbH,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Synexus Clinical Research GmbH, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".